BENEFITS OBSERVED WITH PATIENT-REPORTED OUTCOMES IN A PHASE 2B CLINICAL TRIAL OF GEFAPIXANT, A P2X3 RECEPTOR ANTAGONIST IN CHRONIC COUGH
- Resource Type
- Abstract
- Source
- In
Chest October 2019 156(4) Supplement:A1782-A1783 - Subject
- Language
- ISSN
- 0012-3692